The global market for Mid-Size Pharmaceutical is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Mid-Size Pharmaceutical market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Mid-Size Pharmaceutical market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Mid-Size Pharmaceutical market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Mid-Size Pharmaceutical market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Mid-Size Pharmaceutical players cover DAIICHI SANKYO COMPANY LIMITED, Eisai Co., Ltd., Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc and Sun Pharmaceutical Industries Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Mid-Size Pharmaceutical market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Mid-Size Pharmaceutical market, with both quantitative and qualitative data, to help readers understand how the Mid-Size Pharmaceutical market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Mid-Size Pharmaceutical market and forecasts the market size by Type (Prescription and Over-the-Counter (OTC),), by Application (Cardiovascular Diseases, Pain Management, Diabetes and Cancer), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Prescription
Over-the-Counter (OTC)
Segmentation by application
Cardiovascular Diseases
Pain Management
Diabetes
Cancer
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
DAIICHI SANKYO COMPANY LIMITED
Eisai Co., Ltd.
Bausch Health Companies Inc.
Regeneron Pharmaceuticals, Inc
Sun Pharmaceutical Industries Ltd
Alexion Pharmaceuticals, Inc.
Mallinckrodt
Endo Pharmaceuticals Inc.
Les Laboratories Servier
UCB S.A.
Chapter Introduction
Chapter 1: Scope of Mid-Size Pharmaceutical, Research Methodology, etc.
Chapter 2: Executive Summary, global Mid-Size Pharmaceutical market size and CAGR, Mid-Size Pharmaceutical market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Mid-Size Pharmaceutical revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Mid-Size Pharmaceutical revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Mid-Size Pharmaceutical market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including DAIICHI SANKYO COMPANY LIMITED, Eisai Co., Ltd., Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc, Sun Pharmaceutical Industries Ltd, Alexion Pharmaceuticals, Inc., Mallinckrodt, Endo Pharmaceuticals Inc. and Les Laboratories Servier, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mid-Size Pharmaceutical Market Size 2017-2028
2.1.2 Mid-Size Pharmaceutical Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Mid-Size Pharmaceutical Segment by Type
2.2.1 Prescription
2.2.2 Over-the-Counter (OTC)
2.3 Mid-Size Pharmaceutical Market Size by Type
2.3.1 Mid-Size Pharmaceutical Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Mid-Size Pharmaceutical Market Size Market Share by Type (2017-2022)
2.4 Mid-Size Pharmaceutical Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Pain Management
2.4.3 Diabetes
2.4.4 Cancer
2.4.5 Others
2.5 Mid-Size Pharmaceutical Market Size by Application
2.5.1 Mid-Size Pharmaceutical Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Mid-Size Pharmaceutical Market Size Market Share by Application (2017-2022)
3 Mid-Size Pharmaceutical Market Size by Player
3.1 Mid-Size Pharmaceutical Market Size Market Share by Players
3.1.1 Global Mid-Size Pharmaceutical Revenue by Players (2020-2022)
3.1.2 Global Mid-Size Pharmaceutical Revenue Market Share by Players (2020-2022)
3.2 Global Mid-Size Pharmaceutical Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Mid-Size Pharmaceutical by Regions
4.1 Mid-Size Pharmaceutical Market Size by Regions (2017-2022)
4.2 Americas Mid-Size Pharmaceutical Market Size Growth (2017-2022)
4.3 APAC Mid-Size Pharmaceutical Market Size Growth (2017-2022)
4.4 Europe Mid-Size Pharmaceutical Market Size Growth (2017-2022)
4.5 Middle East & Africa Mid-Size Pharmaceutical Market Size Growth (2017-2022)
5 Americas
5.1 Americas Mid-Size Pharmaceutical Market Size by Country (2017-2022)
5.2 Americas Mid-Size Pharmaceutical Market Size by Type (2017-2022)
5.3 Americas Mid-Size Pharmaceutical Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mid-Size Pharmaceutical Market Size by Region (2017-2022)
6.2 APAC Mid-Size Pharmaceutical Market Size by Type (2017-2022)
6.3 APAC Mid-Size Pharmaceutical Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Mid-Size Pharmaceutical by Country (2017-2022)
7.2 Europe Mid-Size Pharmaceutical Market Size by Type (2017-2022)
7.3 Europe Mid-Size Pharmaceutical Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mid-Size Pharmaceutical by Region (2017-2022)
8.2 Middle East & Africa Mid-Size Pharmaceutical Market Size by Type (2017-2022)
8.3 Middle East & Africa Mid-Size Pharmaceutical Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Mid-Size Pharmaceutical Market Forecast
10.1 Global Mid-Size Pharmaceutical Forecast by Regions (2023-2028)
10.1.1 Global Mid-Size Pharmaceutical Forecast by Regions (2023-2028)
10.1.2 Americas Mid-Size Pharmaceutical Forecast
10.1.3 APAC Mid-Size Pharmaceutical Forecast
10.1.4 Europe Mid-Size Pharmaceutical Forecast
10.1.5 Middle East & Africa Mid-Size Pharmaceutical Forecast
10.2 Americas Mid-Size Pharmaceutical Forecast by Country (2023-2028)
10.2.1 United States Mid-Size Pharmaceutical Market Forecast
10.2.2 Canada Mid-Size Pharmaceutical Market Forecast
10.2.3 Mexico Mid-Size Pharmaceutical Market Forecast
10.2.4 Brazil Mid-Size Pharmaceutical Market Forecast
10.3 APAC Mid-Size Pharmaceutical Forecast by Region (2023-2028)
10.3.1 China Mid-Size Pharmaceutical Market Forecast
10.3.2 Japan Mid-Size Pharmaceutical Market Forecast
10.3.3 Korea Mid-Size Pharmaceutical Market Forecast
10.3.4 Southeast Asia Mid-Size Pharmaceutical Market Forecast
10.3.5 India Mid-Size Pharmaceutical Market Forecast
10.3.6 Australia Mid-Size Pharmaceutical Market Forecast
10.4 Europe Mid-Size Pharmaceutical Forecast by Country (2023-2028)
10.4.1 Germany Mid-Size Pharmaceutical Market Forecast
10.4.2 France Mid-Size Pharmaceutical Market Forecast
10.4.3 UK Mid-Size Pharmaceutical Market Forecast
10.4.4 Italy Mid-Size Pharmaceutical Market Forecast
10.4.5 Russia Mid-Size Pharmaceutical Market Forecast
10.5 Middle East & Africa Mid-Size Pharmaceutical Forecast by Region (2023-2028)
10.5.1 Egypt Mid-Size Pharmaceutical Market Forecast
10.5.2 South Africa Mid-Size Pharmaceutical Market Forecast
10.5.3 Israel Mid-Size Pharmaceutical Market Forecast
10.5.4 Turkey Mid-Size Pharmaceutical Market Forecast
10.5.5 GCC Countries Mid-Size Pharmaceutical Market Forecast
10.6 Global Mid-Size Pharmaceutical Forecast by Type (2023-2028)
10.7 Global Mid-Size Pharmaceutical Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 DAIICHI SANKYO COMPANY LIMITED
11.1.1 DAIICHI SANKYO COMPANY LIMITED Company Information
11.1.2 DAIICHI SANKYO COMPANY LIMITED Mid-Size Pharmaceutical Product Offered
11.1.3 DAIICHI SANKYO COMPANY LIMITED Mid-Size Pharmaceutical Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 DAIICHI SANKYO COMPANY LIMITED Main Business Overview
11.1.5 DAIICHI SANKYO COMPANY LIMITED Latest Developments
11.2 Eisai Co., Ltd.
11.2.1 Eisai Co., Ltd. Company Information
11.2.2 Eisai Co., Ltd. Mid-Size Pharmaceutical Product Offered
11.2.3 Eisai Co., Ltd. Mid-Size Pharmaceutical Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Eisai Co., Ltd. Main Business Overview
11.2.5 Eisai Co., Ltd. Latest Developments
11.3 Bausch Health Companies Inc.
11.3.1 Bausch Health Companies Inc. Company Information
11.3.2 Bausch Health Companies Inc. Mid-Size Pharmaceutical Product Offered
11.3.3 Bausch Health Companies Inc. Mid-Size Pharmaceutical Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bausch Health Companies Inc. Main Business Overview
11.3.5 Bausch Health Companies Inc. Latest Developments
11.4 Regeneron Pharmaceuticals, Inc
11.4.1 Regeneron Pharmaceuticals, Inc Company Information
11.4.2 Regeneron Pharmaceuticals, Inc Mid-Size Pharmaceutical Product Offered
11.4.3 Regeneron Pharmaceuticals, Inc Mid-Size Pharmaceutical Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Regeneron Pharmaceuticals, Inc Main Business Overview
11.4.5 Regeneron Pharmaceuticals, Inc Latest Developments
11.5 Sun Pharmaceutical Industries Ltd
11.5.1 Sun Pharmaceutical Industries Ltd Company Information
11.5.2 Sun Pharmaceutical Industries Ltd Mid-Size Pharmaceutical Product Offered
11.5.3 Sun Pharmaceutical Industries Ltd Mid-Size Pharmaceutical Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sun Pharmaceutical Industries Ltd Main Business Overview
11.5.5 Sun Pharmaceutical Industries Ltd Latest Developments
11.6 Alexion Pharmaceuticals, Inc.
11.6.1 Alexion Pharmaceuticals, Inc. Company Information
11.6.2 Alexion Pharmaceuticals, Inc. Mid-Size Pharmaceutical Product Offered
11.6.3 Alexion Pharmaceuticals, Inc. Mid-Size Pharmaceutical Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Alexion Pharmaceuticals, Inc. Main Business Overview
11.6.5 Alexion Pharmaceuticals, Inc. Latest Developments
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Information
11.7.2 Mallinckrodt Mid-Size Pharmaceutical Product Offered
11.7.3 Mallinckrodt Mid-Size Pharmaceutical Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Mallinckrodt Main Business Overview
11.7.5 Mallinckrodt Latest Developments
11.8 Endo Pharmaceuticals Inc.
11.8.1 Endo Pharmaceuticals Inc. Company Information
11.8.2 Endo Pharmaceuticals Inc. Mid-Size Pharmaceutical Product Offered
11.8.3 Endo Pharmaceuticals Inc. Mid-Size Pharmaceutical Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Endo Pharmaceuticals Inc. Main Business Overview
11.8.5 Endo Pharmaceuticals Inc. Latest Developments
11.9 Les Laboratories Servier
11.9.1 Les Laboratories Servier Company Information
11.9.2 Les Laboratories Servier Mid-Size Pharmaceutical Product Offered
11.9.3 Les Laboratories Servier Mid-Size Pharmaceutical Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Les Laboratories Servier Main Business Overview
11.9.5 Les Laboratories Servier Latest Developments
11.10 UCB S.A.
11.10.1 UCB S.A. Company Information
11.10.2 UCB S.A. Mid-Size Pharmaceutical Product Offered
11.10.3 UCB S.A. Mid-Size Pharmaceutical Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 UCB S.A. Main Business Overview
11.10.5 UCB S.A. Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Mid-Size Pharmaceutical Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Prescription
Table 3. Major Players of Over-the-Counter (OTC)
Table 4. Mid-Size Pharmaceutical Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Mid-Size Pharmaceutical Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Mid-Size Pharmaceutical Market Size Market Share by Type (2017-2022)
Table 7. Mid-Size Pharmaceutical Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Mid-Size Pharmaceutical Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Mid-Size Pharmaceutical Market Size Market Share by Application (2017-2022)
Table 10. Global Mid-Size Pharmaceutical Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Mid-Size Pharmaceutical Revenue Market Share by Player (2020-2022)
Table 12. Mid-Size Pharmaceutical Key Players Head office and Products Offered
Table 13. Mid-Size Pharmaceutical Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Mid-Size Pharmaceutical Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Mid-Size Pharmaceutical Market Size Market Share by Regions (2017-2022)
Table 18. Americas Mid-Size Pharmaceutical Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Mid-Size Pharmaceutical Market Size Market Share by Country (2017-2022)
Table 20. Americas Mid-Size Pharmaceutical Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Mid-Size Pharmaceutical Market Size Market Share by Type (2017-2022)
Table 22. Americas Mid-Size Pharmaceutical Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Mid-Size Pharmaceutical Market Size Market Share by Application (2017-2022)
Table 24. APAC Mid-Size Pharmaceutical Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Mid-Size Pharmaceutical Market Size Market Share by Region (2017-2022)
Table 26. APAC Mid-Size Pharmaceutical Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Mid-Size Pharmaceutical Market Size Market Share by Type (2017-2022)
Table 28. APAC Mid-Size Pharmaceutical Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Mid-Size Pharmaceutical Market Size Market Share by Application (2017-2022)
Table 30. Europe Mid-Size Pharmaceutical Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Mid-Size Pharmaceutical Market Size Market Share by Country (2017-2022)
Table 32. Europe Mid-Size Pharmaceutical Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Mid-Size Pharmaceutical Market Size Market Share by Type (2017-2022)
Table 34. Europe Mid-Size Pharmaceutical Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Mid-Size Pharmaceutical Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Mid-Size Pharmaceutical Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Mid-Size Pharmaceutical Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Mid-Size Pharmaceutical Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Mid-Size Pharmaceutical Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Mid-Size Pharmaceutical Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Mid-Size Pharmaceutical Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Mid-Size Pharmaceutical
Table 43. Key Market Challenges & Risks of Mid-Size Pharmaceutical
Table 44. Key Industry Trends of Mid-Size Pharmaceutical
Table 45. Global Mid-Size Pharmaceutical Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Mid-Size Pharmaceutical Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Mid-Size Pharmaceutical Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Mid-Size Pharmaceutical Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Mid-Size Pharmaceutical Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Mid-Size Pharmaceutical Market Size Market Share Forecast by Application (2023-2028)
Table 51. DAIICHI SANKYO COMPANY LIMITED Details, Company Type, Mid-Size Pharmaceutical Area Served and Its Competitors
Table 52. DAIICHI SANKYO COMPANY LIMITED Mid-Size Pharmaceutical Product Offered
Table 53. DAIICHI SANKYO COMPANY LIMITED Mid-Size Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. DAIICHI SANKYO COMPANY LIMITED Main Business
Table 55. DAIICHI SANKYO COMPANY LIMITED Latest Developments
Table 56. Eisai Co., Ltd. Details, Company Type, Mid-Size Pharmaceutical Area Served and Its Competitors
Table 57. Eisai Co., Ltd. Mid-Size Pharmaceutical Product Offered
Table 58. Eisai Co., Ltd. Main Business
Table 59. Eisai Co., Ltd. Mid-Size Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Eisai Co., Ltd. Latest Developments
Table 61. Bausch Health Companies Inc. Details, Company Type, Mid-Size Pharmaceutical Area Served and Its Competitors
Table 62. Bausch Health Companies Inc. Mid-Size Pharmaceutical Product Offered
Table 63. Bausch Health Companies Inc. Main Business
Table 64. Bausch Health Companies Inc. Mid-Size Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Bausch Health Companies Inc. Latest Developments
Table 66. Regeneron Pharmaceuticals, Inc Details, Company Type, Mid-Size Pharmaceutical Area Served and Its Competitors
Table 67. Regeneron Pharmaceuticals, Inc Mid-Size Pharmaceutical Product Offered
Table 68. Regeneron Pharmaceuticals, Inc Main Business
Table 69. Regeneron Pharmaceuticals, Inc Mid-Size Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Regeneron Pharmaceuticals, Inc Latest Developments
Table 71. Sun Pharmaceutical Industries Ltd Details, Company Type, Mid-Size Pharmaceutical Area Served and Its Competitors
Table 72. Sun Pharmaceutical Industries Ltd Mid-Size Pharmaceutical Product Offered
Table 73. Sun Pharmaceutical Industries Ltd Main Business
Table 74. Sun Pharmaceutical Industries Ltd Mid-Size Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Sun Pharmaceutical Industries Ltd Latest Developments
Table 76. Alexion Pharmaceuticals, Inc. Details, Company Type, Mid-Size Pharmaceutical Area Served and Its Competitors
Table 77. Alexion Pharmaceuticals, Inc. Mid-Size Pharmaceutical Product Offered
Table 78. Alexion Pharmaceuticals, Inc. Main Business
Table 79. Alexion Pharmaceuticals, Inc. Mid-Size Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Alexion Pharmaceuticals, Inc. Latest Developments
Table 81. Mallinckrodt Details, Company Type, Mid-Size Pharmaceutical Area Served and Its Competitors
Table 82. Mallinckrodt Mid-Size Pharmaceutical Product Offered
Table 83. Mallinckrodt Main Business
Table 84. Mallinckrodt Mid-Size Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Mallinckrodt Latest Developments
Table 86. Endo Pharmaceuticals Inc. Details, Company Type, Mid-Size Pharmaceutical Area Served and Its Competitors
Table 87. Endo Pharmaceuticals Inc. Mid-Size Pharmaceutical Product Offered
Table 88. Endo Pharmaceuticals Inc. Main Business
Table 89. Endo Pharmaceuticals Inc. Mid-Size Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Endo Pharmaceuticals Inc. Latest Developments
Table 91. Les Laboratories Servier Details, Company Type, Mid-Size Pharmaceutical Area Served and Its Competitors
Table 92. Les Laboratories Servier Mid-Size Pharmaceutical Product Offered
Table 93. Les Laboratories Servier Main Business
Table 94. Les Laboratories Servier Mid-Size Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Les Laboratories Servier Latest Developments
Table 96. UCB S.A. Details, Company Type, Mid-Size Pharmaceutical Area Served and Its Competitors
Table 97. UCB S.A. Mid-Size Pharmaceutical Product Offered
Table 98. UCB S.A. Main Business
Table 99. UCB S.A. Mid-Size Pharmaceutical Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. UCB S.A. Latest Developments
List of Figures
List of Figures
Figure 1. Mid-Size Pharmaceutical Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Mid-Size Pharmaceutical Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Mid-Size Pharmaceutical Market Size Market Share by Type in 2021
Figure 7. Mid-Size Pharmaceutical in Cardiovascular Diseases
Figure 8. Global Mid-Size Pharmaceutical Market: Cardiovascular Diseases (2017-2022) & ($ Millions)
Figure 9. Mid-Size Pharmaceutical in Pain Management
Figure 10. Global Mid-Size Pharmaceutical Market: Pain Management (2017-2022) & ($ Millions)
Figure 11. Mid-Size Pharmaceutical in Diabetes
Figure 12. Global Mid-Size Pharmaceutical Market: Diabetes (2017-2022) & ($ Millions)
Figure 13. Mid-Size Pharmaceutical in Cancer
Figure 14. Global Mid-Size Pharmaceutical Market: Cancer (2017-2022) & ($ Millions)
Figure 15. Mid-Size Pharmaceutical in Others
Figure 16. Global Mid-Size Pharmaceutical Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Mid-Size Pharmaceutical Market Size Market Share by Application in 2021
Figure 18. Global Mid-Size Pharmaceutical Revenue Market Share by Player in 2021
Figure 19. Global Mid-Size Pharmaceutical Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Mid-Size Pharmaceutical Market Size 2017-2022 ($ Millions)
Figure 21. APAC Mid-Size Pharmaceutical Market Size 2017-2022 ($ Millions)
Figure 22. Europe Mid-Size Pharmaceutical Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Mid-Size Pharmaceutical Market Size 2017-2022 ($ Millions)
Figure 24. Americas Mid-Size Pharmaceutical Value Market Share by Country in 2021
Figure 25. Americas Mid-Size Pharmaceutical Consumption Market Share by Type in 2021
Figure 26. Americas Mid-Size Pharmaceutical Market Size Market Share by Application in 2021
Figure 27. United States Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Mid-Size Pharmaceutical Market Size Market Share by Region in 2021
Figure 32. APAC Mid-Size Pharmaceutical Market Size Market Share by Application in 2021
Figure 33. China Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Mid-Size Pharmaceutical Market Size Market Share by Country in 2021
Figure 40. Europe Mid-Size Pharmaceutical Market Size Market Share by Type in 2021
Figure 41. Europe Mid-Size Pharmaceutical Market Size Market Share by Application in 2021
Figure 42. Germany Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Mid-Size Pharmaceutical Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Mid-Size Pharmaceutical Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Mid-Size Pharmaceutical Market Size Market Share by Application in 2021
Figure 50. Egypt Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Mid-Size Pharmaceutical Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 56. APAC Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 57. Europe Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 59. United States Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 60. Canada Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 63. China Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 64. Japan Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 65. Korea Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 67. India Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 68. Australia Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 69. Germany Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 70. France Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 71. UK Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 72. Italy Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 73. Russia Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 74. Spain Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 77. Israel Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Mid-Size Pharmaceutical Market Size 2023-2028 ($ Millions)